Boston Scientific received approval of its fourth generation Vercise Genus Deep Brain Stimulation (DBS) System. The portfolio, approved for conditional use in a magnetic resonance imaging (MRI) environment, consists of a family of Bluetooth-enabled, rechargeable and non-rechargeable, implantable pulse generators (IPGs) that power Cartesia directional leads.
DBS devices can treat the symptoms of Parkinson’s Disease (PD) by delivering targeted electrical stimulation via surgically implanted leads in the brain connected to an IPG. http://www.bostonscientific.com/dbs
Dakota ACDF is indicated for use in skeletally mature patients with DDD of the cervical spine (C2-T1) at one or two disc levels with DDD defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. https://www.precisionspineinc.com
Longeviti Neuro Solutions received 510(k) clearance for the ClearFit implant for post-operative imaging using ultrasound. A neuro reconstructive implant used by surgeons to reconstruct a patient’s cranium, ClearFit implants are implantable, patient-specific prosthetics. The company’s innovative solutions for complex brain surgery is advancing neurosurgery using low-profile intracranial devices that address the functional and reconstructive needs of patients with neurological conditions. https://longeviti.com
Explore the April 2021 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Viant expands medical device solutions
- MIDACO’s automatic 4-pallet changer with trunnion system
- Breaking Free of the Additive Manufacturing Echo Chamber
- Boston Scientific to Acquire Cortex
- Don’t miss this month’s Manufacturing Lunch + Learn!
- Coating could make medical devices safer for patients
- How robots and cobots can work for you
- Renishaw receives Industry Partner Award
